Diabetes Care, Vol 21, Issue 1 53-61, Copyright © 1998 by American Diabetes Association

ARTICLES

Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with type 2 diabetes. San Luis Valley Diabetes Study, Colorado

SM Tudor, RF Hamman, A Baron, DW Johnson and SM Shetterly
Department of Preventive Medicine and Biometrics, University of Colorado School of Medicine, Denver 80262, USA.

OBJECTIVE: To learn if Hispanic people with type 2 diabetes have excess incidence and/or progression of diabetic retinopathy and to explore the association of risk factors with diabetic retinopathy. RESEARCH DESIGN AND METHODS: There were 244 subjects with type 2 diabetes (65.3% Hispanic) with at least one follow-up visit between 1984 and 1992 examined for the development of retinopathy over a median of 4.8 years (range 2.0-6.6 years). Stereo fundus photos were graded by the University of Wisconsin Reading Center. RESULTS: Of the 169 subjects without retinopathy at baseline, 47 developed some retinopathy, an incidence rate of 63.7 per 1,000 person-years (PY), or a 4-year cumulative incidence of 22.5%. The Hispanic incidence rate was 58.3/1,000 PY (95% CI: 39.4-83.3), which was lower than among non-Hispanic whites, 76.1/1,000 PY (44.3-121.9). Progression occurred in 24 of the 75 subjects with retinopathy at baseline, a 4-year cumulative rate of 24.1%. Logistic regression showed that insulin treatment was associated with higher risk of any retinopathy (odds ratio [OR] = 8.45, 2.65-26.97), and both systolic blood pressure (odds ratio [OR] = 1.58, 0.99-2.52) and total GHb (OR = 1.46, 0.99-2.17) nearly attained statistical significance. After adjustment for multiple potential risk factors, the Hispanic/non-Hispanic white OR was 0.66 (0.28-1.57). CONCLUSIONS: No excess risk for incident retinopathy was found among Hispanic compared with non-Hispanic white subjects in this population. These results are consistent with our previously reported prevalence data from the same population but differ from reports of excess prevalence among Texas Hispanics. No other Hispanic incidence data are available to assist in reconciling this difference.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. H. Arar, B. I. Freedman, S. G. Adler, S. K. Iyengar, E. Y. Chew, M. D. Davis, S. G. Satko, D. W. Bowden, R. Duggirala, R. C. Elston, et al. Heritability of the Severity of Diabetic Retinopathy: The FIND-Eye Study Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 3839 - 3845. [Abstract] [Full Text] [PDF]

				N. Emanuele, J. Sacks, R. Klein, D. Reda, R. Anderson, W. Duckworth, C. Abraira, and for the Veterans Affairs Diabetes Trial Group Ethnicity, Race, and Baseline Retinopathy Correlates in the Veterans Affairs Diabetes Trial Diabetes Care, August 1, 2005; 28(8): 1954 - 1958. [Abstract] [Full Text] [PDF]

				F. A. Sloan, D. S. Brown, E. S. Carlisle, J. Ostermann, and P. P. Lee Estimates of Incidence Rates With Longitudinal Claims Data Arch Ophthalmol, October 1, 2003; 121(10): 1462 - 1468. [Abstract] [Full Text] [PDF]

				M. B. Davidson Effect of Nurse-Directed Diabetes Care in a Minority Population Diabetes Care, August 1, 2003; 26(8): 2281 - 2287. [Abstract] [Full Text] [PDF]

				H. C. Looker, J. Krakoff, W. C. Knowler, P. H. Bennett, R. Klein, and R. L. Hanson Longitudinal Studies of Incidence and Progression of Diabetic Retinopathy Assessed by Retinal Photography in Pima Indians Diabetes Care, February 1, 2003; 26(2): 320 - 326. [Abstract] [Full Text] [PDF]